P. Masolini

发表

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

A. Gabrielli, S. Bombardieri, D. Roccatello, 2012, Arthritis and rheumatism.

P‐glycoprotein (PGP), lung resistance‐related protein (LRP) and multidrug resistance‐associated protein (MRP) expression in acute promyelocytic leukaemia

M. Baccarani, P. Masolini, D. Damiani, 2000, British journal of haematology.

Amifostine Does Not Inhibit the Toxic Effects of Anthracycline Derivates or Mitoxantrone on MDR Tumor Cell Lines

D. Russo, P. Masolini, D. Damiani, 2001, Leukemia & lymphoma.

Liposome‐encapsulated daunorubicin for PGP‐related multidrug resistance

M. Baccarani, F. Pea, D. Russo, 1999, British journal of haematology.

P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.

M. Baccarani, R. Scheper, S. Grimaz, 1998, Haematologica.

Clinical characteristics, prognostic factors and multidrug‐resistance related protein expression in 36 adult patients with acute promyelocytic leukemia

R. Fanin, P. Masolini, D. Damiani, 2003, European journal of haematology.

P‐glycoprotein (PGP) and lung resistance‐related protein (LRP) expression and function in leukaemic blast cells

R. Fanin, M. Baccarani, D. Russo, 1997, British journal of haematology.

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.

M. Cutolo, F. Atzeni, M. Benucci, 2010, Rheumatology.

Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.

M. Baccarani, F. Quadrifoglio, P. Masolini, 1994, Haematologica.

B-cell compartment as the selective target for the treatment of immune thrombocytopenias.

R. Fanin, M. Baccarani, S. De Vita, 2003, Haematologica.

Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells.

R. Fanin, M. Baccarani, D. Russo, 1996, Leukemia & lymphoma.

Long‐Term Effects of Rituximab in Rheumatoid Arthritis

L. Quartuccio, S. De Vita, R. Pellerito, 2009, Annals of the New York Academy of Sciences.

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.

R. Fanin, M. Baccarani, S. De Vita, 2002, Haematologica.

P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications

M. Baccarani, G. Visani, P. Masolini, 1999, British journal of haematology.

organs (heart, liver, and bone marrow) Multipotent cells can be generated in vitro from several adult human

C. Schneider, R. Verardo, R. Fanin, 2012 .

Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow).

C. Schneider, R. Verardo, R. Fanin, 2007, Blood.

P‐glycoprotein, lung resistance‐related protein and multidrug resistance‐associated protein in de novo adult acute lymphoblastic leukaemia

R. Fanin, M. Baccarani, D. Russo, 2002, British journal of haematology.

Antibody binding capacity for evaluation of MDR‐related proteins in acute promyelocytic leukemia: Onset versus relapse expression

R. Fanin, P. Masolini, F. Lauria, 2004, Cytometry. Part B, Clinical cytometry.

Dendritic cells Dendritic cell recovery after autologous stem cell transplantation

R. Fanin, M. Baccarani, P. Masolini, 2002 .

Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B‐CLL) cells

R. Fanin, E. Barbarotto, P. Secchiero, 2005, Journal of cellular physiology.

FLOW CYTOMETRY EVALUATION OF PLASMA CELLS CONTAMINATING LEUKAPHERESIS PRE‐ AND POST‐CD34‐POSITIVE SELECTION

M. Baccarani, F. Patriarca, P. Masolini, 1999, British journal of haematology.

Amifostine feasibility and efficacy in autologous stem cell transplantation for multiple myeloma.

R. Fanin, M. Baccarani, P. Tosi, 2004, Haematologica.

CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection.

R. Fanin, M. Baccarani, P. Masolini, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism

M. Benucci, L. Quartuccio, G. Guarrera, 2012 .

CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.

R. Fanin, P. Masolini, F. Lauria, 2002, Haematologica.

S. Bombardieri, M. Isola, L. Quartuccio, 2013, Clinical and experimental rheumatology.

Dendritic cell recovery after autologous stem cell transplantation

R. Fanin, M. Baccarani, P. Masolini, 2002, Bone Marrow Transplantation.

Biological and clinical features of T‐biphenotypic acute leukaemia: report from a single centre

R. Fanin, E. Calistri, P. Masolini, 2004, British Journal of Haematology.

Investigation on possible cell sources to be utilized for cardiac cell therapy.

C. Beltrami, D. Cesselli, N. Bergamin, 2005, Pathologica.

Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.

M. Boccadoro, E. Barbieri, A. Longo, 1994, Haematologica.

Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance.

M. Baccarani, P. Masolini, D. Damiani, 1999, Haematologica.